| EP3960164 - METHOD FOR PRODUCING PHARMACEUTICAL FORMULATION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.12.2023 Database last updated on 21.03.2026 | |
| Former | Request for examination was made Status updated on 28.01.2022 | ||
| Former | The international publication has been made Status updated on 31.10.2020 | Most recent event Tooltip | 01.12.2023 | Application deemed to be withdrawn | published on 03.01.2024 [2024/01] | Applicant(s) | For all designated states Nipro Corporation 9-3, Honjo-nishi 3-chome Kita-ku Osaka-shi, Osaka 531-8510 / JP | [2022/09] | Inventor(s) | 01 /
NAKANO Yoshio c/o NIPRO CORPORATION, 9-3, Honjo-nishi 3-chome Kita-ku Osaka-shi, Osaka 531-8510 / JP | 02 /
HAYASHIDA Tomohiro c/o NIPRO CORPORATION, 9-3, Honjo-nishi 3-chome Kita-ku Osaka-shi, Osaka 531-8510 / JP | 03 /
HOASHI Yohei c/o NIPRO CORPORATION, 9-3, Honjo-nishi 3-chome Kita-ku Osaka-shi, Osaka 531-8510 / JP | 04 /
EDAMURA Keisuke c/o NIPRO CORPORATION, 9-3, Honjo-nishi 3-chome Kita-ku Osaka-shi, Osaka 531-8510 / JP | 05 /
ICHIKAWA Yuki c/o NIPRO CORPORATION, 9-3, Honjo-nishi 3-chome Kita-ku Osaka-shi, Osaka 531-8510 / JP | [2022/09] | Representative(s) | Reitstötter Kinzebach Patentanwälte Sternwartstraße 4 81679 München / DE | [N/P] |
| Former [2022/09] | Reitstötter Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE | Application number, filing date | 20795882.8 | 21.04.2020 | [2022/09] | WO2020JP17254 | Priority number, date | JP20190081372 | 22.04.2019 Original published format: JP 2019081372 | [2022/09] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020218310 | Date: | 29.10.2020 | Language: | JA | [2020/44] | Type: | A1 Application with search report | No.: | EP3960164 | Date: | 02.03.2022 | Language: | EN | [2022/09] | Search report(s) | International search report - published on: | JP | 29.10.2020 | (Supplementary) European search report - dispatched on: | EP | 14.12.2022 | Classification | IPC: | A61J3/06, A61J3/00, A61K9/20, A61K31/137, A61K31/519, A61K31/558, A61K9/28 | [2023/02] | CPC: |
A61K9/2866 (EP);
A61K9/28 (US);
A61J3/005 (EP);
A61K31/137 (EP,US);
A61K31/519 (EP);
A61K31/558 (EP);
A61K9/2013 (US);
A61K9/2018 (US);
A61K9/2027 (US);
A61K9/2054 (US);
A61K9/2059 (US);
A61K9/2086 (EP);
|
| Former IPC [2022/09] | A61K9/28, A61K9/44, A61K9/48, A61J3/06 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/09] | Title | German: | VERFAHREN ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN FORMULIERUNG | [2022/09] | English: | METHOD FOR PRODUCING PHARMACEUTICAL FORMULATION | [2022/09] | French: | PROCÉDÉ POUR PRODUIRE UNE FORMULATION PHARMACEUTIQUE | [2022/09] | Entry into regional phase | 22.10.2021 | Translation filed | 22.10.2021 | National basic fee paid | 22.10.2021 | Search fee paid | 22.10.2021 | Designation fee(s) paid | 22.10.2021 | Examination fee paid | Examination procedure | 22.10.2021 | Examination requested [2022/09] | 06.05.2022 | Amendment by applicant (claims and/or description) | 28.11.2022 | Observations by third parties | 22.07.2023 | Application deemed to be withdrawn, date of legal effect [2024/01] | 14.08.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2024/01] | Fees paid | Renewal fee | 29.04.2022 | Renewal fee patent year 03 | 28.04.2023 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] WO2005123569 (SMITHKLINE BEECHAM CORP et al.) [X] 1-20 * page 17, paragraph 88 - page 19, paragraph 92 * * page 21, paragraph 99 - page 23, paragraph 103 * * page 30, paragraph 122 - page 33, paragraph 130 * * page 41, paragraph 153 * * page 42, paragraph 157 - page 43, paragraph 158 * * page 46, paragraph 167 - page 47, paragraph 168 * * page 71, paragraphs 227-228 * * claim - * | [X] GB2512098 (BUFTON ROLY et al.) [X] 1-8,11-18 * page 5, lines 3-31 * * page 6, line 26 - page 7, line 18 * * page 14, lines 8-23 * * page 15, line 26 - page 17, line 25 * * claim - * | [X] US2006002986 (CLARKE ALLAN J et al.) [X] 1-20 * page 2, paragraphs 23-27 * * page 4, paragraphs 81-84 * * page 7, paragraphs 120-122 * * page 15, paragraph 206 - page 16, paragraph 209 * * page 16, paragraph 217 - page 17, paragraph 221 * * claim - * | International search | [XY] JP2012254974 (XEROX CORP et al.) [X] 1-3, 5-6, 11-15, 17-18 [Y] 1-20 | [XY] JPS55108815 (THOMAE GMBH DR K) [X] 1-2, 4, 11-14, 16 [Y] 1-20 | [Y] JP2006528191 [Y] 1-20 | [Y] JP2006528192 [Y] 1-20 | [Y] WO2006126561 (EISAI R&D MAN CO LTD et al.) [Y] 1-20 | [Y] JP2017057344 (SCREEN HOLDINGS CO LTD et al.) [Y] 1-20 | [Y] WO2016117518 (QUALICAPS CO LTD et al.) [Y] 1-20 | by applicant | JP2006006303 | US4322449 | JP2006063030 | other | JP3215836 | WO2005123569 | US2005202051 | US2019336396 | JP2016203235 | JP2016203218 | JP3215836 | NAOKO KISU ET AL.: "Particle containment in pharmaceutical equipment (Containment) Performance Evaluation", SCAS NEWS, vol. I, 1 January 2013 (2013-01-01), pages 7 - 10, XP093010466 |